openPR Logo
Press release

Gastroparesis Drugs Market Comprehensive Study by Leading Key Players: Allergan, Plc., Abbott Laboratories (Abbott Arzneimittel GmbH), AstraZeneca Plc., Cadila Pharmaceuticals Ltd., ETX Pharma, Inc. and more

01-04-2019 10:56 AM CET | Health & Medicine

Press release from: Allied Market Research

Gastroparesis Drugs Market

Gastroparesis Drugs Market

The Gastroparesis Drugs Market is valued at $ 4,667 million in 2016 and is expected to reach $ 6,486 million at an annual average growth rate of 4.7% from 2017 to 2023.

Gastroparesis affects the normal spontaneous movement of the stomach muscles and therefore interferes with normal digestion, causing nausea, vomiting, blood sugar levels and nutritional problems. Gastric paralysis can be caused by diabetes or after surgery. Recently, advanced drugs such as metoclopramide, erythromycin, and anti-vomiting drugs have been developed to treat gastroparesis.

The major factors that drive the growth of the global gastroparesis drugs market are rise in number of surgeries that may lead to postoperative gastroparesis, increase in diabetic population, introduction of novel drugs, and surge in geriatric population.

However, side effects associated with gastroparesis drugs and time-consuming regulatory approvals are expected to restrain the market growth. Conversely, huge untapped market potential in the emerging countries, such as China and India, and development of novel gastroparesis drugs are expected to provide lucrative opportunities to the market players.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4153?utm_source=sy

The list of key players profiled in this report Include
• Allergan Plc.
• Abbott Laboratories (Abbott Arzneimittel GmbH)
• AstraZeneca Plc.
• Cadila Pharmaceuticals Ltd.
• ETX Pharma Inc
• Evoke Pharma
• GlaxoSmithKline Plc.
• Neurogastrx Inc.
• Valeant Pharmaceuticals International Inc.
• Theravance Biopharma.

Key players in the value chain include Altos Therapeutics LLC, Mylan N.V., Hexal AG, CEVA Group PLC, and Takeda Pharmaceutical Company Ltd.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/4153?utm_source=sy

The prokinetic agents segment occupied the largest share in 2016, owing to the high usage, applicability, and availability of prokinetic agents for treating gastroparesis. Furthermore, the botulinum toxin injection segment is expected to grow at the highest CAGR of 5.6% from 2017 to 2023, and is anticipated to continue its dominance during the forecast period. The utilization rate of gastroparesis drugs for idiopathic gastroparesis is high, however post-surgical gastroparesis segment is expected to grow at a CAGR of 5.2% during the forecast period. This is attributed to increase in incidence of various types of surgeries, such as transplantation, which result in postsurgical gastroparesis.

Key findings of the Gastroparesis Drugs Market:
• Prokinetic agents segment accounted for more than four-fifths share of the global gastroparesis drugs market in 2016.
• Botulinum toxin injection segment is expected to grow at a CAGR of 5.6% from 2017 to 2023.
• Idiopathic gastroparesis segment accounted for around 34.9% share of the global gastroparesis drugs market in 2016.
• Hospitals accounted for nearly two-fifths share of the global gastroparesis drugs market in 2016.
• Pharmacies segment is expected to grow at a CAGR of 5.0% from 2017 to 2023

North America was the leading revenue contributor to the global gastroparesis drugs market, accounting for nearly one-third of the global market. This is attributed to the early approval of gastroparesis drugs and high use of these drugs due to rise in incidence of gastroparesis. However, Asia-Pacific is expected to grow at the highest CAGR of 5.5% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward gastroparesis drugs.

Access Full Summery @ https://www.alliedmarketresearch.com/gastroparesis-drugs-market?utm_source=sy

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastroparesis Drugs Market Comprehensive Study by Leading Key Players: Allergan, Plc., Abbott Laboratories (Abbott Arzneimittel GmbH), AstraZeneca Plc., Cadila Pharmaceuticals Ltd., ETX Pharma, Inc. and more here

News-ID: 1471184 • Views:

More Releases from Allied Market Research

Home Exercise Bike Market is expected to witness robust Compound Annual Growth Rate (CAGR) progress of 8.7% from 2021 to 2027.
Home Exercise Bike Market is expected to witness robust Compound Annual Growth R …
According to a new report published by Allied Market Research, titled, "Home Exercise Bike Market by Type, and Sales Channel: Opportunity Analysis and Industry Forecast, 2021-2027," The global home exercise bike market size was valued at $1,213.5 million in 2019, and is projected to reach $2,335.2 million by 2027, registering a CAGR of 8.7% from 2021 to 2027. The recumbent segment is expected to retain its dominant position, in terms
Rapidly expanding entertainment products industry is set to drive the growth of the $103.8 billion Toys market ; Ravensburger AG, Tomy Company, Ltd, Vtech Holdings, and Thames & Kosmos.
Rapidly expanding entertainment products industry is set to drive the growth of …
According to a new report published by Allied Market Research, titled, "Toys Market by Product Type, Age Group and Sales Channel: Opportunity Analysis and Industry Forecast, 2021-2027," the toys market size was $92.2 billion in 2019, and is projected reach $103.8 billion by 2027, registering a CAGR of 2.5% from 2021 to 2027. The increase in number of games bars, cafes and family entertainment centers worldwide is boosting the demand for
Global Home Beer Brewing Machine Market is expected to reach $25.4 million by the year 2030, as projected by Allied Market Research.
Global Home Beer Brewing Machine Market is expected to reach $25.4 million by th …
According to a new report published by Allied Market Research, titled, "home beer brewing machine market by product type, mechanism, and distribution channel: global opportunity analysis and industry forecast, 2021-2030," The global home beer brewing machine market size was valued at $19.1 million in 2020, and is projected to reach $25.4 million by 2030, registering a CAGR of 3.0% from 2021 to 2030. Request a report sample to gain comprehensive insights
Hospitality Robots Market is forecasted to grow at a Compound Annual Growth Rate (CAGR) of 25.5% through the year 2030, according to Allied Market Research.
Hospitality Robots Market is forecasted to grow at a Compound Annual Growth Rate …
According to a new report published by Allied Market Research, titled, "Hospitality Robots Market by Type, End User, Sales Channel and Region: Global Opportunity Analysis and Industry Forecast, 2021-2030," The global hospitality robots market size is expected to reach $3,083 million by 2030 at a CAGR of 25.5% from 2021 to 2030. Hospitality Robots Market by Type (Front Desk Robots, Delivery Robots, Cleaning Robots and Others) and end user (Hotels,

All 5 Releases


More Releases for Gastroparesis

Gastroparesis Drugs Market Analysis by 2020-2025
Scope of the Report: The worldwide market for Gastroparesis Drugsis expected to grow at a CAGR of roughly x% over the next five years, will reach x million US$ in 2024, from x million US$ in 2019, according to a new Global Info Researchstudy. The report presents the market outlook for the Indian Phospho Gypsum product from the year 2019 to the year 2025. The report provides a definition of the product.
Gastroparesis Drugs Market - Use of Gastroparesis Drugs Is Highest In North Amer …
The Gastroparesis Drugs Market is projected to reach $ 6,448.6 billion, an average annual rate of 4.7% from 2017 to 2023. Gastric paralysis affects the normal spontaneous movement of the gastrointestinal muscles and interferes with normal digestion, causing problems related to nausea, vomiting and blood sugar levels and nutrition. Gastroparesis can be caused by diabetes or after surgery. Recently, advanced drugs such as metoclopramide, erythromycin, and anti-vomiting have been developed to
Diabetic Gastroparesis-Pipeline Review H1 2017
ReportsWeb.com has announced the addition of the “Diabetic Gastroparesis-Pipeline Review H1 2017” this report provides an overview of the Diabetic Gastroparesis-Pipeline landscape.  Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H1 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels can damage nerves in many parts
Diabetic Gastroparesis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Diabetic Gastroparesis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H2 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels
Gastroparesis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, Gastroparesis Global Clinical Trials Review, H2, 2017" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status
Diabetic Gastroparesis - Pipeline Market Research Report, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Diabetic Gastroparesis - Pipeline Insight, 2017”. This report provides comprehensive insights about pipeline drugs across this Diabetic Gastroparesis. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Diabetic Gastroparesis. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1214082 This report provides information on the therapeutic development for